AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Index of articles > Business > Trade Industries publications > Chemical Business Newsbase articles > April 2011 articles
Close

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-255023757/cancer-drug-trials-mersana.html" title="Facts and information about With cancer drug in trials, Mersana Therapeutics Inc gets $6 M.">With cancer drug in trials, Mersana Therapeutics Inc gets $6 M.</a>
Close Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds

With cancer drug in trials, Mersana Therapeutics Inc gets $6 M.

Chemical Business Newsbase

| April 22, 2011 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Mersana Therapeutics Inc (Mersana) has raised $6 M of a planned $10 M debt round with private investors, the company reported in a regulatory filing on 21 Apr 2011. The Cambridge company develops medicines using a proprietary, biodegradable polymer …

View articles courtesy of your local library
Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily